|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 62.13 CNY | -0.78% |
|
-2.40% | -8.73% |
| 03-03 | Gan & Lee Pharmaceuticals Gets Regulatory Nod for Prostate Cancer Drug Trials | MT |
| 01-22 | Gan & Lee Pharmaceuticals Expects 2025 Profit to Jump Up to 95% | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GAN & LEE PHARMACEUTICALS. | Biopharmaceuticals | -0.78% | -2.40% | -8.73% | +32.33% | -50.02% | 5.36B |  |  |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- 603087 Stock
- Charts Gan & Lee Pharmaceuticals.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition